Inventor · disambiguated record
Yung Chyung
Also filed as: CHYUNG YUNG
6 granted patents·12 pending applications·48 citations·filing 2014–2024
82Inventor score
Top patents by PatentIndex Score
18 records- 0195US11084884B2Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 10, 2021·23 cites·17 claims
- 0290US10946036B2Use of myostatin inhibitors and combination therapiesSCHOLAR ROCK INC·Filed 2017·Granted Mar 16, 2021·6 cites·22 claims
- 0388US11286307B2Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attackTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 29, 2022·7 cites·19 claims
- 0488US11155611B2Compositions and methods for making and using anti-myostatin antibodiesSCHOLAR ROCK INC·Filed 2018·Granted Oct 26, 2021·5 cites·7 claims
- 0587US11156612B2Methods of determining levels of cleaved and/or intact kininogenTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 26, 2021·6 cites·15 claims
- 0683US12384854B2Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedemaTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Aug 12, 2025·1 cites·15 claims
- 0765US2022169749A1Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attackTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 0864US2022106390A1Methods for treating metabolic diseases by inhibiting myostatin activationSCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 0964US2022170936A1Evaluation and treatment of bradykinin-mediated disordersTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1062US2022315668A1Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attackTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1162US2025011417A1Methods for the treatment of thyroid eye diseaseTOURMALINE BIO INC·Filed 2024·Application pending·0 cites
- 1262US2025011416A1Methods for the treatment of cardiovascular diseaseTOURMALINE BIO INC·Filed 2024·Application pending·0 cites
- 1361US2025066467A1Methods for the treatment of myasthenia gravisTOURMALINE BIO INC·Filed 2023·Application pending·0 cites
- 1459US2021283166A1Use of myostatin inhibitors and combination therapiesSCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 1557US2025326827A1Use of myostatin inhibitor for treating spinal muscular atrophySCHOLAR ROCK INC·Filed 2023·Application pending·0 cites
- 1655US2024368262A1A myostatin pathway inhibitor in combination with a glp-1 pathway activator for use in treating metabolic disordersSCHOLAR ROCK INC·Filed 2022·Application pending·0 cites
- 1753US2024002490A1Use of anti-pro/latent myostatin antibody for treating spinal muscular atrophySCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 1852US2018298110A1Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attackDYAX CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yung Chyung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →